Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients.

Blood Cancer J · 2025 · PMC12501290 · PMID 41052991

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, in patients who already experienced BT before transplant, the difference in PTS between those with BM blasts at the time of ASCT of <5% (30 months) and those with BM blasts of ≥5% (18 months) did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.